rs1356154563
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_015474.4(SAMHD1):c.1293A>T(p.Leu431Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000559 in 1,611,320 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015474.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAMHD1 | NM_015474.4 | c.1293A>T | p.Leu431Phe | missense_variant | Exon 12 of 16 | ENST00000646673.2 | NP_056289.2 | |
SAMHD1 | NM_001363729.2 | c.1293A>T | p.Leu431Phe | missense_variant | Exon 12 of 15 | NP_001350658.1 | ||
SAMHD1 | NM_001363733.2 | c.1293A>T | p.Leu431Phe | missense_variant | Exon 12 of 16 | NP_001350662.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251284Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135850
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1459150Hom.: 0 Cov.: 29 AF XY: 0.00000275 AC XY: 2AN XY: 726096
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74352
ClinVar
Submissions by phenotype
Aicardi-Goutieres syndrome 5 Pathogenic:1Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 431 of the SAMHD1 protein (p.Leu431Phe). This variant is present in population databases (no rsID available, gnomAD 0.004%). This missense change has been observed in individual(s) with Aicardi-Goutieres syndrome (PMID: 30275001; external communication). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 559589). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SAMHD1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
The SAMHD1 Leu431Phe (p.L431F) is an apparently novel missense variant that changes a single conserved amino acid from leucine to phenylalanine. Although this variant is not within either of the known functional protein domains, other nearby mutations have been associated with disease (Rice 2009, PMID: 19525956). This variant is absent from the ExAC database but observed in 1/24030 alleles in the GnomAD African population (allele frequency 0.00004). This variant has a score of 0.732 by the REVEL metapredictor (Ioannidis 2016, PMID: 27666373), which is below the ClinGen threshold cut-off (0.75) for application of ACMG/AMP in silico prediction evidence. This variant was observed in trans with a second missense variant (Ile201Asn), which is classified as likely pathogenic, in a patient with symptoms highly consistent with Aicardi-Goutieres syndrome. In summary, the Leu431Phe variant is currently considered a variant of uncertain significance based on ACMG/AMP criteria (PM2, PM3, PP4). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at